<code id='8785E1BA13'></code><style id='8785E1BA13'></style>
    • <acronym id='8785E1BA13'></acronym>
      <center id='8785E1BA13'><center id='8785E1BA13'><tfoot id='8785E1BA13'></tfoot></center><abbr id='8785E1BA13'><dir id='8785E1BA13'><tfoot id='8785E1BA13'></tfoot><noframes id='8785E1BA13'>

    • <optgroup id='8785E1BA13'><strike id='8785E1BA13'><sup id='8785E1BA13'></sup></strike><code id='8785E1BA13'></code></optgroup>
        1. <b id='8785E1BA13'><label id='8785E1BA13'><select id='8785E1BA13'><dt id='8785E1BA13'><span id='8785E1BA13'></span></dt></select></label></b><u id='8785E1BA13'></u>
          <i id='8785E1BA13'><strike id='8785E1BA13'><tt id='8785E1BA13'><pre id='8785E1BA13'></pre></tt></strike></i>

          fashion

          fashion

          author:comprehensive    Page View:2514
          A scientist working at SQZ Biotechnologies in Watertown's Arsenal Yards. -- biotech coverage from STAT
          A scientist working at SQZ Biotechnologies in Watertown, Mass. David L Ryan/Globe Staff

          Next stop: Beacon Hill.

          Governor Maura Healey’s long-awaited plan to double down on state funding for the biotech and medical technology sector came into focus Thursday with the announcement she’ll seek $1 billion over the next decade to reauthorize the state’s 16-year-old life sciences initiative.

          advertisement

          But lawmakers so far are noncommittal on funding the plan. The proposal — dubbed “Life Sciences 3.0″ — is part of a larger economic development bill the Healey administration is expected to file soon. Several expressed support for an industry in which Massachusetts is a leader, but also noted the spending request comes at a time of competing priorities.

          Get unlimited access to award-winning journalism and exclusive events.

          Subscribe Log In

          knowledge

          23andMe had bad news about my health. I wish a person had delivered it
          23andMe had bad news about my health. I wish a person had delivered it

          ERICBARADAT/AFP/GettyImagesLastsummer,IthoughtitmightbefuntohavemyDNAanalyzed.Twocompanies,23andMean

          read more
          Winners, losers from Medicare’s list of drugs subject to price talks
          Winners, losers from Medicare’s list of drugs subject to price talks

          AdobeOnTuesdaymorning,theDepartmentofHealthandHumanServicesunveileditslong-awaitedlistofthe10medicin

          read more
          The cancer drug shortage isn’t new — and neither are the solutions
          The cancer drug shortage isn’t new — and neither are the solutions

          PreparingachemotherapytreatmentatDukeCancerCenterinDurham,N.C.GerryBroome/APAyounggirl,maybe5or6year

          read more

          As pharma fights Medicare drug negotiation, hospitals, docs silent

          AdobeThepharmaceuticalindustryhasbeenupinarmsoverMedicare’sfirstlistof10prescriptiondrugsthatwillbes